Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.35
Delayed Data
As of Jul 27
 -0.05 / -3.57%
Today’s Change
0.78
Today|||52-Week Range
1.88
+36.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues43.1M42.6M34.5M31.2M
 
 
 
 
 
Cost of Goods Sold35.8M--0.00--
 
 
Depreciation And Amortization5.3M4.3M232.0K0.00
 
 
 
 
 
Operating ExpensesGross Income2.0M--34.3M--
 
 
 
General Expenses17.4M31.2M11.3M2.4M
 
 
 
 
 
Research And Development--21.0M2.7M0.00
 
 
 
Total Operating Expenses58.5M35.5M11.6M2.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.4M7.1M22.9M28.8M
 
 
 
 
 
Extraordinary Credit5.0M177.0K----
 
 
 
Extraordinary Charge-6.0M-11.5M-4.8M--
 
 
 
 
Interest Expense On Debt5.9M5.3M2.1M0.00
 
 
 
 
Other Expenses91.0K912.0K1.9M61.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.6M-6.9M18.1M28.9M
 
 
 
 
 
Income Taxes-205.0K-4.1M-28.0K-56.0K
 
 
 
 
 
Net Income-20.8M-2.8M18.2M28.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.9M46.7M43.8M44.1M
 
 
 
 
 
Shares To Calculate EPS Diluted51.9M46.7M51.0M44.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.40-$0.06$0.38$0.65
 
 
 
 
 
EPS Diluted-$0.40-$0.06$0.36$0.65
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account